EMA Fast-Tracks Regeneron Gene Therapy for Rare Hearing Loss
Regeneron Pharmaceuticals said the European Medicines Agency (EMA) has accepted for review under its Accelerated…
Trending
- EMA Fast-Tracks Regeneron Gene Therapy for Rare Hearing Loss
- Concept Life Sciences, OpenBench Partner on AI Drug Discovery
- Bristol Myers Squibb Expands AI Push With Anthropic
- Fujifilm Expands Stem Cell Manufacturing in Wisconsin
- Lilly’s Retatrutide Shows Strong Weight Loss in Phase 3
- Gilead Completes $3.15 Billion Tubulis Acquisition
- Gilead, WHO Renew Kala-Azar Elimination Partnership
- J&J, Abu Dhabi Launch Global Surgical AI Network
- Regeneron Reports Promising Amyloidosis Trial Results
- Lilly Acquires Engage to Expand Genetic Medicine Pipeline
Top Headlines
Concept Life Sciences, OpenBench Partner on AI Drug Discovery
Concept Life Sciences has entered a strategic partnership with OpenBench to accelerate early-stage drug discovery…
Bristol Myers Squibb Expands AI Push With Anthropic
Bristol Myers Squibb and Anthropic have entered a strategic agreement to deploy Anthropic’s Claude artificial…
Fujifilm Expands Stem Cell Manufacturing in Wisconsin
FUJIFILM Cellular Dynamics has inaugurated a new headquarters and induced pluripotent stem cell (iPSC) development…
Lilly’s Retatrutide Shows Strong Weight Loss in Phase 3
Eli Lilly and Company reported positive topline results from its Phase 3 TRIUMPH-1 clinical trial, showing that…
Gilead Completes $3.15 Billion Tubulis Acquisition
Gilead Sciences has completed its previously announced acquisition of Germany-based biotechnology company Tubulis…
Featured Event
Clinical Trials
Regeneron Reports Promising Amyloidosis Trial Results
Regeneron Pharmaceuticals reported encouraging early-stage results from a Phase 1/2 clinical trial evaluating Lynozyfic (linvoseltamab) in patients…
Merck Phase 3 Trial Shows Promise in Endometrial Cancer
Global pharmaceutical company Merck & Co. has announced positive pivotal Phase 3 results for sacituzumab tirumotecan (sac-TMT), an investigational…
VOLGA Trial Shows Promise in Muscle-Invasive Bladder Cancer
AstraZeneca announced positive interim results from the Phase III VOLGA clinical trial, showing that perioperative treatment with Imfinzi combined…
Madrigal Licenses Gene Therapy Candidate for MASH Treatment
Madrigal Pharmaceuticals, Inc. has entered into an exclusive global licensing agreement with Arrowhead Pharmaceuticals to develop and commercialize…
Akeso Advances First Trispecific Antibody Into Clinical Trials
Akeso, Inc. has announced that its novel trispecific antibody candidate, AK150, has received Investigational New Drug (IND) clearance from the…
Vima Therapeutics Advances Dystonia Drug Into Phase 2 Trials
Vima Therapeutics has announced significant progress in the development of its experimental treatment for movement disorders, revealing that the first…
Fast shipping, security and absolute privacy is our main goal Viagra-Buy.com/ savings on their medication from a licensed and certified pharmacy.
The best pharmacy in america Viagra-Buy.com Fast delivery, best prices and for real men
Concept Life Sciences, OpenBench Partner on AI Drug Discovery
Concept Life Sciences has entered a strategic partnership with OpenBench to accelerate early-stage drug discovery…
QIAGEN, NVIDIA Expand AI Drug Discovery Collaboration
QIAGEN announced a new collaboration with NVIDIA aimed at integrating accelerated computing and artificial…
Drug Research
Latus Bio Raises $97 Million to Advance Gene Therapies
Latus Bio, Inc. has secured $97 million in Series A financing to accelerate the development of its gene therapy…
UK Streamlines Drug Approvals to Accelerate Patient Access
The Medicines and Healthcare products Regulatory Agency (MHRA) and National Institute for Health and Care…
Novartis Targets Breast Cancer With Novel PI3Kα Inhibitor Deal
Novartis has announced a strategic agreement with Synnovation Therapeutics, LLC to acquire SNV4818, an…
FDA Proposes New Steps to Streamline Biosimilar Drug Development
The U.S. Food and Drug Administration has announced a new regulatory initiative aimed at accelerating the…
Insilico, CMS Partner on AI Drug Discovery Programs
Clinical-stage biotechnology company Insilico Medicine and pharmaceutical commercialization group China Medical…
Manufacturing
Fujifilm Expands Stem Cell Manufacturing in Wisconsin
FUJIFILM Cellular Dynamics has inaugurated a new headquarters and induced pluripotent stem cell (iPSC) development…
Piramal, Ajinomoto Partner to Advance ADC Manufacturing Capabilities
Piramal Pharma Solutions and Ajinomoto Bio-Pharma Services have announced a strategic collaboration aimed at…
UCB Selects Georgia for Major U.S. Biologics Manufacturing Hub
UCB has announced plans to establish a major new biologics manufacturing facility in Gwinnett County, Georgia,…
LGM Pharma Expands U.S. Manufacturing With $15M Investment
LGM Pharma has announced a $9 million expansion across its U.S. manufacturing network, marking the second phase of…
Terumo BCT, Taiwan Bio Partner on Treg Manufacturing
Terumo Blood and Cell Technologies (Terumo BCT) has entered into a strategic collaboration with Taiwan Bio…
CordenPharma Leases New Lab Facility at Boulder’s Flatiron Park
BioMed Realty has announced that CordenPharma Colorado has signed a long-term lease for a new laboratory facility…
Novo Nordisk Invests €432M to Expand Irish GLP-1 Manufacturing
Pharmaceutical giant Novo Nordisk has announced a €432 million investment to expand its manufacturing facility in…
AbbVie Invests $380M in North Chicago Manufacturing
AbbVie has unveiled plans to invest $380 million to construct two new active pharmaceutical ingredient (API)…
Diseases
Tenaya and Alnylam Partner to Discover New Genetic Targets for Heart Disease
Clinical-stage biotechnology company Tenaya Therapeutics has announced a new research collaboration with RNA…
AstraZeneca, CSPC Partner on Next-Generation Obesity Therapies
AstraZeneca has strengthened its weight management and metabolic disease pipeline through a new strategic…
China Approves ENHERTU for Second-Line HER2-Positive Gastric Cancer
China’s National Medical Products Administration (NMPA) has approved ENHERTU® (trastuzumab deruxtecan) for the…
InterAx, Alveus Partner to Advance Next-Generation Obesity Therapy
InterAx Biotech Ltd and Alveus Therapeutics Inc. have entered into a strategic research collaboration and licensing…
Sandoz to Acquire Just-Evotec Biologics Facility in Toulouse Under New Term Sheet
Sandoz has signed a non-binding term sheet with Evotec SE to potentially acquire Just–Evotec Biologics EU SAS,…
AstraZeneca and Revna Biosciences Expand Lung Cancer Treatment Access in Ghana
Since announcing their partnership in April 2025, AstraZeneca and Revna Biosciences have made significant strides…
